Emergent BioSolutions | EBS - Ebitda





Ebitda Perubahan Tanggal
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Akebia Therapeutics USD 14.03M 17.19M 2025-03
ALKERMES USD 100.31M 21.24M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Coherus Biosciences USD -44.34M 9.82M 2025-03
Exact Sciences USD 135.42M 2.8M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Lonza CHF 1.01B 54M 2025-12
Merck USD 8.39B 1.97B 2025-09
Moderna USD -790M 582M 2025-12
Myriad Genetics USD 10.3M 4.2M 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Pacira USD 38.71M 10.65M 2025-12
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD 20.63M 53.74M 2025-09
Sanofi EUR 4.84B 2.95B 2025-09
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
United Therapeutics USD 379.5M 83.4M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Xoma USD 2.52M 7.98M 2024-06